C07D 213/88
Nicotinoylhydrazones
C07D213/88 (Nicotinoylhydrazones) appears on 14 US grants and 6 published applications in this corpus.
Search patents in C07D- Granted patents
- 14
- Published applications
- 6
- Assignees
- 13
- Inventors
- 57
- Latest grant
- 4 Nov 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 2 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 2 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 1 |
| 2007 | 0 | 1 |
| 2008 | 1 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 1 | 1 |
| 2012 | 0 | 0 |
| 2013 | 1 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 1 |
| 2024 | 0 | 0 |
| 2025 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Continuous flow synthesis method for the manufacture of isoniazid4 Nov 2025US 12,459,897 B2Nelson Mandela University
- Quinazoline derivatives which promote the release of parathyroid hormone2 Jul 2013US 8,476,286 B2Novartis AG
- Use of metal complex compounds as oxidation catalysts19 Apr 2011US 7,928,049 B2BASF SE Ludwigshafen
- Method and probe for identifying bacterial virulence modifying agents, agents thus identified, and their use1 Apr 2008US 7,351,861 B2Innate Pharmaceuticals AB
- Hydrazide compounds7 Aug 2001US 6,271,247 B1Adir et Compagnie
- A continuous flow synthesis method for the manufacture of isoniazid11 May 2023US 2023/0142405 A1Nelson Mandela University
- Use of metal complex compounds as oxidation catalysts27 Jan 2011US 2011/0021407 A1Ciba Corporation
- Aminopyridine derivatives as modulators of mglur530 Apr 2009US 2009/0111823 A1AstraZeneca AB
- Anti-parasitic compounds and methods of their use23 Aug 2007US 2007/0197495 A1The Regents of the University of California
- Method and probe for identifying bacterial virulence modifying agents, agents thus identifed, and their use22 Jun 2006US 2006/0134724 A1Innate Pharmaceuticals AB
Most cited
By later US patents
- Hydrazide compounds44US 6,172,108 B2Adir et Compagnie · 2001
- Amide derivatives having ACAT inhibitory activity, their preparation and their therapeutic and prohylactic use28US 5,880,147 ASankyo Company, Limited · 1999
- Urea derivatives having ACAT inhibitory activity, their preparation and their therapeutic and prophylactic use27US 6,040,339 ASankyo Company, Limited · 2000
- Anthelmintic pyridinyl acylhydrazones14US 5,023,334 AThe Upjohn Company · 1991
- Use of metal complex compounds as oxidation catalysts14US 7,928,049 B2BASF SE Ludwigshafen · 2011